Azithromycine et pathologies bronchiques chroniques : quels patients ? Quels bénéfices ? Quelles modalités ?
Origin | Files produced by the author(s) |
---|
Origin | Files produced by the author(s) |
---|
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.univ-brest.fr/hal-02081032
Submitted on : Monday, October 25, 2021-9:23:21 AM
Last modification on : Tuesday, October 3, 2023-10:38:03 AM
Long-term archiving on : Wednesday, January 26, 2022-6:50:14 PM